RCEL (AVITA Medical, Inc.) Total Enterprise Value
AVITA Medical, Inc. (RCEL) generates revenue by supplying skin restoration systems to clinics and plastic surgeons. Business scalability is driven by the expansion of medical indications without requiring capital expenditure for construction. The global humanitarian status of the products ensures protection from trade wars and sanctions. This chart of current quotes on GURU.Markets reflects an Enterprise Value of 436.77.
Financial and market metric breakdowns for AVITA Medical, Inc. (RCEL)
Enterprise Value determines the total acquisition price of a business by summing market capitalization and debt obligations minus liquid assets. By analyzing the market equivalent of the enterprise value, an investor assesses the premium or discount, considering the increasing predictability of AVITA Medical (RCEL) revenues from the sale of skin regeneration systems and the expansion of their clinical application within the hospital sector.